There's still time to register for the 'Need for Even Faster Acting Insulins to Improve Patient Outcomes Symposium' on 2 March. Listen to different perspectives on ultra-rapid acting insulins and advancements being made in developing even faster products. https://t.co/2XvXmYucCS
Arecor has gone blue for World Diabetes Day - we are developing rapid and concentrated insulin products that we hope will help patients better manage their diabetes and make their lives more simple, healthier and happier for it #diabetes#worlddiabetesday
We’re excited to share the announcement of positive results for the first Phase I Clinical Trial of AT247, a novel ultra-rapid acting insulin, presented at yesterday’s ADA. Find out more at https://t.co/eSOqlwH0TB #ADA2020#ADAGoesVirtual#diabetes#insulin
🚨Temporary Support Needed
@CUH_NHS are looking to recruit people with previous healthcare/admin experience to work in a variety of areas within the hospital, on an adhoc/short term basis
If you are able to support us in any way, apply at https://t.co/mziwLvcHs5
Please retweet
A decade of research by @_RomanHovorka has led to the world’s first downloadable artificial pancreas app, licensed for people with #type1diabetes in UK: https://t.co/6P0nJ0Zd5h
@MRL_Cam @JDRF @DiabetesUK@NIHRresearch@CambridgeBRC
BREAKING NEWS! The first #artificialpancreas app from @Cambridge_Uni's Professor @_RomanHovorka launches today. Your support has achieved this milestone. JDRF and researchers will work to help make it available on the NHS for everyone with #type1diabetes. https://t.co/YHxbojBrWI
AP-Renal study (NCT04025775) aims to find out if fully closed-loop insulin delivery can improve glucose control for people with type 2 diabetes on dialysis #worldkidneyday#kidsneysmatter @MRL_Cam @CamMetaboNet
Today @UKParliament we launch our report #PathwayToChoice - to build awareness and access to #type1diabetes technologies. It will reveal to MPs the barriers, motivations and opportunities around wearable medical technology faced by people with #type1. https://t.co/R4LtaVA94V
Health professionals' views about who would benefit from using a closed-loop system: a qualitative study, with @_RomanHovorka as a co-author, published now in @DiabeticMed https://t.co/JwE4D67cnY #closedloop#type1diabetes#diabetes#insulinpump